Who owns Amneal Pharmaceuticals, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of AMRX from SEC Form 13F filings across 334 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 334 institutions disclosed 169.2M shares of Amneal Pharmaceuticals, Inc. worth $3.41B — about 50.4% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
334
13F holders
$3.41B
value, 2026 filers
50.4%
of shares outstanding (169.2M sh)
61
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of AMRX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 26.9M | $541.3M | 0.0% | 8% | +1.2% |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 12.4M | $249.0M | 0.0% | 3.7% | +1.9% |
| 3 | TPG GP A, LLC | 12.3M | $248.3M | 6.0% | 3.7% | 0.0% |
| 4 | Rubric Capital Management LP | 8.5M | $171.9M | 1.6% | 2.5% | -16.0% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 8.0M | $160.9M | 0.0% | 2.4% | +3.6% |
| 6 | STATE STREET CORP | 7.5M | $150.5M | 0.0% | 2.2% | +1.6% |
| 7 | CITADEL ADVISORS LLC | 7.0M | $140.9M | 0.0% | 2.1% | +525.2% |
| 8 | Invesco Ltd. | 6.0M | $120.1M | 0.0% | 1.8% | +70.3% |
| 9 | DIMENSIONAL FUND ADVISORS LP | 5.8M | $117.1M | 0.0% | 1.7% | +0.4% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 4.6M | $92.0M | 0.0% | 1.4% | -11.1% |
| 11 | MORGAN STANLEY | 4.3M | $86.0M | 0.0% | 1.3% | +3.9% |
| 12 | Allspring Global Investments Holdings, LLC | 3.8M | $76.9M | 0.1% | 1.1% | +16.3% |
| 13 | NEUBERGER BERMAN GROUP LLC | 3.4M | $67.5M | 0.0% | 1% | -13.8% |
| 14 | Nuveen, LLC | 3.2M | $64.4M | 0.0% | 1% | -3.8% |
| 15 | GOLDMAN SACHS GROUP INC | 2.6M | $52.3M | 0.0% | 0.8% | -13.9% |
| 16 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.5M | $49.9M | 0.0% | 0.7% | +15.4% |
| 17 | Tri Locum Partners LPNEW | 2.3M | $46.9M | 9.3% | 0.7% | new |
| 18 | Nantahala Capital Management, LLC | 2.1M | $42.6M | 1.3% | 0.6% | -6.7% |
| 19 | Assenagon Asset Management S.A. | 2.0M | $40.8M | 0.0% | 0.6% | -17.1% |
| 20 | NORTHERN TRUST CORP | 1.8M | $36.7M | 0.0% | 0.5% | -4.8% |
| 21 | AMERIPRISE FINANCIAL INC | 1.6M | $31.3M | 0.0% | 0.5% | -1.8% |
| 22 | CONGRESS ASSET MANAGEMENT CO | 1.5M | $30.7M | 0.2% | 0.5% | +94.7% |
| 23 | Balyasny Asset Management L.P. | 1.3M | $27.1M | 0.0% | 0.4% | +209.4% |
| 24 | ACADIAN ASSET MANAGEMENT LLC | 1.3M | $26.1M | 0.0% | 0.4% | -21.5% |
| 25 | VANGUARD FIDUCIARY TRUST CO | 1.2M | $24.7M | 0.0% | 0.4% | +5.1% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.